TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
TNGX

Tango Therapeutics Inc

Healthcare · Biotechnology · —

25.50$ +14.3% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

Tango Therapeutics Inc (TNGX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,074 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TNGX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
428 403 406 381 352 316 274 238 210 399 436 1,074
371 347 352 328 301 266 225 190 164 354 392 1,032
59 66 61 52 53 70 58 39 58 112 158 346
360 337 344 322 293 258 217 181 153 343 380 1,014
0.0 0.0
152 149 142 134 123 117 108 103 50 53 44 49
43 46 43 44 38 38 36 40 18 22 14 20
2.0 2.1 2.1 2.4 2.9 2.5 2.8 2.5 3.1 2.7 2.8 2.9
2.8 2.8 3.9 1.1 4.1 1.6 3.2 2.6 2.2 1.2 2.4 1.8
277 253 264 248 229 200 167 135 160 346 392 1,025
-340 -371 -409 -435 -464 -502 -541 -580 -564 -603 -649 -704
97 96 108 108 109 109 110 111 111 116 144 150

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?